{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:57:39Z","timestamp":1780624659830,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neubiorev.2025.106340","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:03:09Z","timestamp":1755496989000},"page":"106340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antidepressant use in dementia: Assessing effective strategies for a vulnerable population"],"prefix":"10.1016","volume":"177","author":[{"given":"Mariagiovanna","family":"Cozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Luca","family":"Fimognari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-1122","authenticated-orcid":false,"given":"Virginia","family":"Boccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2025.106340_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.638651","article-title":"Depression in alzheimer's disease: a delphi consensus on etiology, risk factors, and clinical management","volume":"12","author":"Ag\u00fcera-Ortiz","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-020-00194-2","article-title":"Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in alzheimer's disease mice","volume":"9","author":"Ai","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2025.106340_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2025.45","article-title":"Late-life affective disorders and risk of progression to dementia: retrospective cohort study of patients in secondary care","volume":"31","author":"Alexander","year":"2025","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41398-019-0514-6","article-title":"Mechanisms and treatment of late-life depression","volume":"9","author":"Alexopoulos","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106340_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2165\/0002512-200825120-00005","article-title":"Adherence to medication in patients with dementia: predictors and strategies for improvement","volume":"25","author":"Arlt","year":"2008","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib6","doi-asserted-by":"crossref","first-page":"17r11772","DOI":"10.4088\/JCP.17r11772","article-title":"Meta-Analysis of the prevalence of major depressive disorder among older adults with dementia","volume":"79","author":"Asmer","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17070","article-title":"Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","volume":"17","author":"Banerjee","year":"2013","journal-title":"Health Technol. Assess."},{"issue":"10310","key":"10.1016\/j.neubiorev.2025.106340_bib8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(21)01210-1","article-title":"Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial","volume":"398","author":"Banerjee","year":"2021","journal-title":"Lancet"},{"issue":"344","key":"10.1016\/j.neubiorev.2025.106340_bib9","article-title":"Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial","volume":"9","author":"Bergh","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106340_bib10","first-page":"1","article-title":"A tool for safer prescribing in vulnerable adults: the continuing development of the medichec app and website","volume":"48","author":"Bishara","year":"2023","journal-title":"BJPsych Bull."},{"key":"10.1016\/j.neubiorev.2025.106340_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2014.12.053","article-title":"The course of depressive symptoms as measured by the cornell scale for depression in dementia over 74 months in 1158 nursing home residents","volume":"175","author":"Borza","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106340_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jagp.2016.06.005","article-title":"The depressed frail phenotype: the clinical manifestation of increased biological aging","volume":"24","author":"Brown","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib13","first-page":"525","article-title":"Review of bupropion","volume":"2","author":"Bryant","year":"1983","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1567205017666200217104114","article-title":"Depression in dementia or dementia in depression? Systematic review of studies and hypotheses","volume":"17","author":"Brzezi\u0144ska","year":"2020","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/NDT.S3201","article-title":"The efficacy of mirtazapine in agitated patients with alzheimer's disease: a 12-week open-label pilot study","volume":"4","author":"Cakir","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179399","article-title":"Depression in dementia with lewy bodies: a comparison with alzheimer's disease","volume":"12","author":"Chiu","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archneurol.2009.92","article-title":"Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of alzheimer type","volume":"66","author":"Chow","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106340_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jad.2023.06.024","article-title":"Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: the MEMORY study","volume":"338","author":"Christensen","year":"2023","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106340_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1017\/S003329172200397X","article-title":"Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance","volume":"53","author":"Costello","year":"2023","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106340_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WAD.0b013e3181e6a4d7","article-title":"Treating neuropsychiatric symptoms in dementia with lewy bodies: a randomized controlled-trial","volume":"24","author":"Culo","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neubiorev.2025.106340_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.JGP.0000221293.91312.d3","article-title":"Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders","volume":"14","author":"Cummings","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.36150\/2499-6564-N320","article-title":"Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use","volume":"69","author":"Cuomo","year":"2021","journal-title":"J. Gerontol. Geriatr."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: a class-by-class review of literature","volume":"55","author":"De Picker","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neubiorev.2025.106340_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102445","article-title":"Suicide and dementia: a systematic review and meta-analysis of prevalence and risk factors","volume":"100","author":"Desai","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.neubiorev.2025.106340_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jagp.2018.05.008","article-title":"Donepezil treatment in patients with depression and cognitive impairment on stable antidepressant treatment: a randomized controlled trial","volume":"26","author":"Devanand","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106340_bib28","article-title":"Antidepressants for treating depression in dementia","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","article-title":"Depression in dementia: epidemiology, mechanisms, and treatment","volume":"24","author":"Enache","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib30","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2147\/NDT.S434130","article-title":"Trazodone in the management of major depression among elderly patients with dementia: a narrative review and clinical insights","volume":"19","author":"Fagiolini","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/gps.4566","article-title":"What is the therapeutic value of antidepressants in dementia? A narrative review","volume":"32","author":"Farina","year":"2017","journal-title":"Int J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12877-020-01730-5","article-title":"Use of antidepressant medications among older adults in european long-term care facilities: a cross-sectional analysis from the SHELTER study","volume":"20","author":"Giovannini","year":"2020","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin","year":"2007","journal-title":"Dialog. Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106340_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/02698811211030181","article-title":"Efficacy of antidepressant drugs in the treatment of depression in alzheimer disease patients: a systematic review and network meta-analysis","volume":"35","author":"He","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106340_bib35","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/jgs.15508","article-title":"Cumulative antidepressant use and risk of dementia in a prospective cohort study","volume":"66","author":"Heath","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106340_bib36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.biopsych.2023.10.008","article-title":"Depression in alzheimer's disease: epidemiology, mechanisms, and treatment","volume":"95","author":"Huang","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/893905","article-title":"Dysthymia and apathy: diagnosis and treatment","author":"Ishizaki","year":"2011","journal-title":"Depress Res Treat."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.9758\/cpn.2022.20.2.311","article-title":"Vortioxetine treatment for depression in alzheimer's disease: a randomized, Double-blind, Placebo-controlled study","volume":"20","author":"Jeong","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106340_bib39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S1041610220004032","article-title":"Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis","volume":"33","author":"Jester","year":"2021","journal-title":"Int. Psychogeriatr."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106340_bib40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgs.12730","article-title":"Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel","volume":"62","author":"Kales","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1176\/jnp.2010.22.1.19","article-title":"Frontotemporal dementia and pharmacologic interventions","volume":"22","author":"Kaye","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/00989134-20070101-06","article-title":"Anticholinergic medications: use among older adults with memory problems","volume":"33","author":"Kemper","year":"2007","journal-title":"J. Gerontol. Nurs."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106340_bib43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/jnnp.2003.031773","article-title":"Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?","author":"Kessing","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-161251","article-title":"A Meta-Analysis of memantine for depression","volume":"57","author":"Kishi","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18773\/austprescr.2015.071","article-title":"Depression in dementia","volume":"38","author":"Kitching","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.neubiorev.2025.106340_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/jnp.17.3.342","article-title":"Prevalence of apathy, dysphoria, and depression in relation to dementia severity in alzheimer's disease","volume":"17","author":"Landes","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106340_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-3223(03)00543-2","article-title":"Depression in alzheimer's disease: heterogeneity and related issues","volume":"54","author":"Lee","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S2215-0366(20)30383-7","article-title":"The association between loneliness and depressive symptoms among adults aged 50 years and older: a 12-year population-based cohort study","volume":"8","author":"Lee","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116114","article-title":"Antidepressants for treating depression among older adults with dementia: a systematic review and meta-analysis","volume":"340","author":"Lenouvel","year":"2024","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2016.15020248","article-title":"Effects of citalopram on neuropsychiatric symptoms in alzheimer's dementia: evidence from the CitAD study","volume":"173","author":"Leonpacher","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnagi.2018.00038","article-title":"When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate alzheimer's disease from Late-Life depression","volume":"10","author":"Liguori","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/13554794.2016.1211711","article-title":"Bupropion improved apathy in behavioral variant frontotemporal dementia: a case report","volume":"22","author":"Lin","year":"2016","journal-title":"Neurocase"},{"issue":"10452","key":"10.1016\/j.neubiorev.2025.106340_bib53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106340_bib54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/14656566.2018.1471136","article-title":"Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder","volume":"19","author":"Lozupone","year":"2018","journal-title":"Expert Opin. Pharm."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.JGP.0000221334.65330.55","article-title":"Position statement of the American association for geriatric psychiatry regarding principles of care for patients with dementia resulting from alzheimer disease","volume":"14","author":"Lyketsos","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6027","article-title":"Bupropion for the treatment of apathy in alzheimer disease: a randomized clinical trial","volume":"3","author":"Maier","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12877-019-1327-4","article-title":"Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty","volume":"19","author":"Mallery","year":"2019","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib58","first-page":"20","article-title":"Consensus of the SEPG on depression in the elderly","volume":"39","author":"Mart\u00edn-Carrasco","year":"2011","journal-title":"Actas Esp. Psiquiatr"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the centers for Medicare & medicaid Services\u2019 national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"4-5","key":"10.1016\/j.neubiorev.2025.106340_bib60","first-page":"131","article-title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in alzheimer patients","volume":"47","author":"Mokhber","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0b013e31802e0002","article-title":"Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial","volume":"27","author":"Mowla","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106340_bib62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-148004","article-title":"Phenomenology of depression in alzheimer's disease","volume":"47","author":"Novais","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00019442-200203000-00003","article-title":"Provisional diagnostic criteria for depression of alzheimer disease","volume":"10","author":"Olin","year":"2002","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106340_bib64","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in alzheimer's disease: systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.14283\/jpad.2023.132","article-title":"Vortioxetine treatment for depression in patients with prodromal vs mild alzheimer's disease: a Six-Month, Open-Label, observational study","volume":"11","author":"Padovani","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035147","article-title":"Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care","volume":"10","author":"Peakman","year":"2020","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106340_bib67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/jnp.8.3.270","article-title":"A double-blind placebo-controlled study of clomipramine in depressed patients with alzheimer's disease","volume":"8","author":"Petracca","year":"1996","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106340_bib68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/geriatrics6010005","article-title":"Dementia and major neurocognitive disorders: some lessons learned one century after the first alois Alzheimer\u2019s clinical notes","volume":"6","author":"Petretto","year":"2021","journal-title":"Geriatrics"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40520-024-02772-0","article-title":"The Italian guideline on comprehensive geriatric assessment (CGA) for the older persons: a collaborative work of 25 Italian scientific societies and The National institute of health","volume":"36","author":"Pilotto","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib70","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib71","article-title":"Escitalopram for agitation in Alzheimer\u2019s dementia","volume":"20","author":"Rajji","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib72","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib73","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/TCRM.S395449","article-title":"Discontinuation of antidepressants in older adults: a literature review","volume":"19","author":"Romdhani","year":"2023","journal-title":"Ther. Clin. Risk Manag"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106340_bib75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3122\/jabfm.2012.03.100183","article-title":"Guidelines for the management of cognitive and behavioral problems in dementia","volume":"25","author":"Sadowsky","year":"2012","journal-title":"J. Am. Board Fam. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106340_bib76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib77","first-page":"40","article-title":"Antidepressant drugs: disturbing and potentially dangerous adverse effects","volume":"59","author":"Settle","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib78","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: a 28-Year Follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"16","key":"10.1016\/j.neubiorev.2025.106340_bib79","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.1997.03550160083043","article-title":"Diagnosis and treatment of alzheimer disease and related disorders. Consensus statement of the American association for geriatric psychiatry, the alzheimer's association, and the American geriatrics society","volume":"278","author":"Small","year":"1997","journal-title":"JAMA 2229"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272315","article-title":"Depressive symptoms before and after parkinson's diagnosis-A longitudinal analysis","volume":"17","author":"Song","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1520-6394(2000)12:1+<63::AID-DA8>3.0.CO;2-T","article-title":"Efficacy of venlafaxine in geriatric depression","volume":"12","author":"Staab","year":"2000","journal-title":"Depress Anxiety"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106340_bib82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jamapsychiatry.2017.0658","article-title":"Late-Life depression and the prodromes of dementia","volume":"74","author":"Steffens","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2022.104204","article-title":"Comparative efficacy of 11 non-pharmacological interventions on depression, anxiety, quality of life, and caregiver burden for informal caregivers of people with dementia: a systematic review and network meta-analysis","volume":"129","author":"Sun","year":"2022","journal-title":"Int J. Nurs. Stud."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib84","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JGP.0b013e318165dbae","article-title":"Diagnosing depression in alzheimer disease with The National institute of mental health provisional criteria","volume":"16","author":"Teng","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106340_bib85","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.14336\/AD.2021.0526","article-title":"Depression and dementia in older adults: a neuropsychological review","volume":"12","author":"Tetsuka","year":"2021","journal-title":"Aging Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106340_bib86","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674370705200407","article-title":"Efficacy and safety of antidepressants for treatment of depression in alzheimer's disease: a metaanalysis","volume":"52","author":"Thompson","year":"2007","journal-title":"Can. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106340_bib87","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/biomedicines12061232","article-title":"Predictive models for the transition from mild neurocognitive disorder to major neurocognitive disorder: insights from clinical, demographic, and neuropsychological data","volume":"12","author":"Tsiakiri","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106340_bib88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000102570","article-title":"A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia","volume":"24","author":"de Vasconcelos Cunha","year":"2007","journal-title":"Dement Geriatr. Cogn. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.2019.74","article-title":"The association of late-life depression with all-cause and cardiovascular mortality among community-dwelling older adults: systematic review and meta-analysis","volume":"215","author":"Wei","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106340_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13195-024-01475-y","article-title":"Association between depression and young-onset dementia in middle-aged women","volume":"16","author":"Yoo","year":"2024","journal-title":"Alz Res Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.1990.00530020117023","article-title":"Neurochemical correlates of major depression in primary dementia","volume":"47","author":"Zubenko","year":"1990","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106340_bib92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410240210","article-title":"The neuropathology of aminergic nuclei in alzheimer's disease","volume":"24","author":"Zweig","year":"1988","journal-title":"Ann. Neurol."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T22:05:09Z","timestamp":1762034709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425003410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":92,"alternative-id":["S0149763425003410"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106340","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant use in dementia: Assessing effective strategies for a vulnerable population","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106340"}}